Related Experiment Video
Updated: Aug 1, 2025
14:23
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
Published on: April 16, 2012
24.2K
Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond
Sebastian Bittner1, Thomas Hehlgans2, Markus Feuerer2
1Leibniz Institute for Immunotherapy, Division of Immunology, 93053 Regensburg, Germany.
Trends in Immunology
|April 26, 2023
Summary
Regulatory T (Treg) cells show promise for treating inflammatory and autoimmune diseases. Engineering Treg cells with biosensors and novel functions could expand their therapeutic applications and diagnostic capabilities.
Area of Science:
- Immunology
- Cell Therapy
- Biotechnology
Background:
- Regulatory T (Treg) cells are crucial for maintaining self-tolerance and regulating immune responses.
- Treg cell therapies have demonstrated safety and efficacy in early clinical trials for inflammatory conditions.
- The therapeutic potential of Treg cells extends to autoimmune disorders and transplant rejection.
Purpose of the Study:
- To review recent advancements in engineering Treg cells for therapeutic applications.
- To explore novel functional modifications for Treg cells, including enhanced stability, migration, and tissue adaptation.
- To discuss future perspectives of engineered Treg cells as diagnostic tools and drug delivery systems.
Main Methods:
- Review of current literature on Treg cell engineering and immunotherapy.
- Analysis of strategies for incorporating biosensors into Treg cells for inflammation detection.
- Assessment of methods for modifying Treg cell function, stability, and tissue targeting.
Main Results:
- Engineering Treg cells offers new possibilities for treating inflammatory and autoimmune diseases.
- Biosensor integration enables Treg cells to detect and respond to inflammatory environments.
- Modifications can improve Treg cell persistence, homing, and function in target tissues.
Conclusions:
- Engineered Treg cells hold significant therapeutic promise beyond current applications.
- Custom-designed receptors and read-out systems can transform Treg cells into in vivo diagnostic tools.
- Future Treg cell engineering aims to utilize them as sophisticated drug delivery vehicles and diagnostic agents.
Related Concept Videos
01:24T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
185
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
185
01:27Tumor Immunotherapy
593
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
593